aluminum hydroxide/magnesium carbonate (Gaviscon Extra Strength Liquid, Gaviscon Extra Strength Tablets, Gaviscon Regular Strength Liquid)
Classes: Antacids, Combos
- Dosing and uses of Gaviscon Extra Strength Tablets and Liquid (aluminum hydroxide/magnesium carbonate)
- Gaviscon Extra Strength Tablets and Liquid (aluminum hydroxide/magnesium carbonate) adverse (side) effects
- Warnings
- Pregnancy
- Pharmacology of Gaviscon Extra Strength Tablets and Liquid (aluminum hydroxide/magnesium carbonate)
Dosing and uses of Gaviscon Extra Strength Tablets and Liquid (aluminum hydroxide/magnesium carbonate)
Adult dosage forms and strengths
aluminum hydroxide/magnesium carbonate
tablet, chewable
- 160mg/105mg
suspension, oraL
- (31.7mg/119.3mg)/5mL
- (84.6mg/79.1mg)/5mL
Gastric Hyperacidity, Heartburn
Extra Strength Tablets: Chew 2-4 tablets PO q6hr PRN; not to exceed 16 tablets/day
Extra Strength Suspension: 15-30 mL PO q6hr PRN; not to exceed 80 mL/day
Regular Strength Suspension: 15-30 mL PO q6hr PRN; not to exceed 120 mL/day
Pediatric dosage forms and strengths
Safety & efficacy not established
Gaviscon Extra Strength Tablets and Liquid (aluminum hydroxide/magnesium carbonate) adverse (side) effects
Frequency not defined
Aluminum
- Chalky taste
- Constipation
- Fecal impaction
- Stomach cramps
- Nausea
- Vomiting
- Aluminum intoxication
- Hypophosphatemia
- Osteomalacia
Magnesium
- Diarrhea
- Hypermagnesemia
Warnings
Contraindications
Hypersensitivity
Cautions
Renal failure
Magnesium restricted diet
May increase or decrease rate and/or degree of absorption of concomitantly administered oral drugs by changing GI transit time, pH, or by cationic binding
Pregnancy and lactation
Pregnancy category: C
Lactation: Unknown whether distributed in breast milk
Pregnancy categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA: Information not available.
Pharmacology of Gaviscon Extra Strength Tablets and Liquid (aluminum hydroxide/magnesium carbonate)
Mechanism of action
Neutralizes gastric acidity by increasing gastric pH
